Medgenics seeks U.S. listing

Medgenics Inc. (LSE:MEDG) proposed to list its shares on NYSE Amex and raise $17.3 million in a financing underwritten by Roth and Maxim. Medgenic's lead candidate, Epodure, is a transdermal biopump i...